Lymph node-targeting nanovaccines for cancer immunotherapy
Q Wang, Z Wang, X Sun, Q Jiang, B Sun, Z He… - Journal of Controlled …, 2022 - Elsevier
Cancer immunotherapies such as tumor vaccines, chimeric antigen receptor T cells and
immune checkpoint blockades, have attracted tremendous attention. Among them, tumor …
immune checkpoint blockades, have attracted tremendous attention. Among them, tumor …
Antiviral properties of polyphenols from plants
Polyphenols are active substances against various types of viral infections. Researchers
have characterized methods of how to isolate polyphenols without losing their potential to …
have characterized methods of how to isolate polyphenols without losing their potential to …
Nanovaccines fostering tertiary lymphoid structure to attack mimicry nasopharyngeal carcinoma
Z Wen, H Liu, D Qiao, H Chen, L Li, Z Yang, C Zhu… - ACS …, 2023 - ACS Publications
Tertiary lymphoid structures (TLSs) are formed in inflamed tissues, and recent studies
demonstrated that the appearance of TLSs in tumor sites is associated with a good …
demonstrated that the appearance of TLSs in tumor sites is associated with a good …
Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy
A He, X Li, Z Dai, Q Li, Y Zhang, M Ding, Z Wen… - Journal of …, 2023 - Springer
Therapeutic tumor vaccines have attracted considerable attention in the past decade; they
can induce tumor regression, eradicate minimal residual disease, establish lasting immune …
can induce tumor regression, eradicate minimal residual disease, establish lasting immune …
Supramolecular polyphenol‐DNA microparticles for in vivo adjuvant and antigen co‐delivery and immune stimulation
DNA‐based materials have attracted interest due to the tunable structure and encoded
biological functionality of nucleic acids. A simple and general approach to synthesize DNA …
biological functionality of nucleic acids. A simple and general approach to synthesize DNA …
[HTML][HTML] Engineering customized nanovaccines for enhanced cancer immunotherapy
J Guo, C Liu, Z Qi, T Qiu, J Zhang, H Yang - Bioactive Materials, 2024 - Elsevier
Nanovaccines have gathered significant attention for their potential to elicit tumor-specific
immunological responses. Despite notable progress in tumor immunotherapy, nanovaccines …
immunological responses. Despite notable progress in tumor immunotherapy, nanovaccines …
Flash technology-based self-assembly in nanoformulation: Fabrication to biomedical applications
Advances in nanoformulation have driven progress in biomedicine by producing nanoscale
tools for biosensing, imaging, and drug delivery. Flash-based technology, the combination of …
tools for biosensing, imaging, and drug delivery. Flash-based technology, the combination of …
CCR7 mediated mimetic dendritic cell vaccine homing in lymph node for head and neck squamous cell carcinoma therapy
J Xu, H Liu, T Wang, Z Wen, H Chen, Z Yang… - Advanced …, 2023 - Wiley Online Library
Immunotherapy has been recognized as one of the most promising treatment strategies for
head and neck squamous cell carcinoma (HNSCC). As a pioneering trend of …
head and neck squamous cell carcinoma (HNSCC). As a pioneering trend of …
A generally minimalist strategy of constructing biomineralized high-efficiency personalized nanovaccine combined with immune checkpoint blockade for cancer …
S Zhang, Y Feng, M Meng, Z Li, H Li, L Lin, C Xu… - Biomaterials, 2022 - Elsevier
As a representative of tumor immunotherapy, tumor vaccine can inhibit tumor growth by
activating tumor-specific immune response, which has the advantages of relatively low …
activating tumor-specific immune response, which has the advantages of relatively low …
Nanovaccines for cancer prevention and immunotherapy: an update review
X Fang, H Lan, K Jin, D Gong, J Qian - Cancers, 2022 - mdpi.com
Simple Summary Cancer vaccines are a promising immunotherapy-based agents used in
cancer therapy. However, monotherapy with these vaccines does not have the sufficient …
cancer therapy. However, monotherapy with these vaccines does not have the sufficient …